Refractory Caffeine and Ergot-induced Cervico-cerebral Vasospasm and Stroke Treated with Combined Medical and Endovascular Approach

Overview

Journal Neuroradiology

Specialties Neurology
Radiology

Date 2011 Apr 7

PMID 21468675

Citations 1

Authors

Megan Miller

Avinash B Kumar

Charles R Callison

Affiliations

Soon will be listed here.

Citing Articles

The Migraine-Stroke Connection.

Lee M, Lee C, Chung C J Stroke. 2016; 18(2):146-56.

PMID: 27283278 PMC: 4901947. DOI: 10.5853/jos.2015.01683.

References

Allen G, Ahn H, Preziosi T, Battye R, Boone S, CHOU S . Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983; 308(11):619-24. DOI: 10.1056/NEJM198303173081103. View

Silberstein S, Young W . Safety and efficacy of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Working Panel of the Headache and Facial Pain Section of the American Academy of Neurology. Neurology. 1995; 45(3 Pt 1):577-84. DOI: 10.1212/wnl.45.3.577. View

Tfelt-Hansen P, Ostergaard J, Gothgen I, Jacobsen E, Rasmussen J, Husum B . Nitroglycerin for ergotism. Experimental studies in vitro and in migraine patients and treatment of an overt case. Eur J Clin Pharmacol. 1982; 22(2):105-9. DOI: 10.1007/BF00542453. View

Linton R, Band D, Haire K . A new method of measuring cardiac output in man using lithium dilution. Br J Anaesth. 1993; 71(2):262-6. DOI: 10.1093/bja/71.2.262. View

Goodson K, Lapointe M, Monroe T, Chalela J . Intraventricular nicardipine for refractory cerebral vasospasm after subarachnoid hemorrhage. Neurocrit Care. 2007; 8(2):247-52. DOI: 10.1007/s12028-007-9017-z. View

Stillman A, Weinberg M, Mast W, Palpant S . Ischemic bowel disease attributable to ergot. Gastroenterology. 1977; 72(6):1336-7. View

Millikan C . Cerebral vasospasm and ruptured intracranial aneurysm. Arch Neurol. 1975; 32(7):433-49. DOI: 10.1001/archneur.1975.00490490037003. View

Lindboe C, Dahl T, Rostad B . Fatal stroke in migraine: a case report with autopsy findings. Cephalalgia. 1989; 9(4):277-80. DOI: 10.1046/j.1468-2982.1989.0904277.x. View

Lee K, Lukovits T, Friedman J . "Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit Care. 2006; 4(1):68-76. DOI: 10.1385/NCC:4:1:068. View

10.

Newell D, Eskridge J, Mayberg M, Grady M, Winn H . Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg. 1989; 71(5 Pt 1):654-60. DOI: 10.3171/jns.1989.71.5.0654. View

11.

Kassell N, Peerless S, Durward Q, Beck D, Drake C, Adams H . Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery. 1982; 11(3):337-43. DOI: 10.1227/00006123-198209000-00001. View

12.

Shibuya M, Suzuki Y, Enomoto H, Okada T, Ogura K, Sugita K . Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 1994; 131(1-2):19-25. DOI: 10.1007/BF01401450. View

13.

Kasuya H, Onda H, Takeshita M, Okada Y, Hori T . Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke. 2002; 33(4):1011-5. DOI: 10.1161/01.str.0000014563.75483.22. View

14.

Badjatia N, Topcuoglu M, Pryor J, Rabinov J, Ogilvy C, Carter B . Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol. 2004; 25(5):819-26. PMC: 7974508. View

15.

Haley Jr E, Kassell N, Torner J . A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study. J Neurosurg. 1993; 78(4):548-53. DOI: 10.3171/jns.1993.78.4.0548. View

16.

Salvesen R, Prytz J . Limb-threatening ischemia due to ergotamine: case report with angiographic evidence. Headache. 2000; 40(4):320-3. DOI: 10.1046/j.1526-4610.2000.00048.x. View

17.

Schmidt R, FANCHAMPS A . Effect of caffeine on intestinal absorption of ergotamine in man. Eur J Clin Pharmacol. 1974; 7(3):213-6. DOI: 10.1007/BF00560383. View